Plain-English translation of NCT04079049 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a major research study testing whether surgical removal of cancer spots in the liver, combined with standard chemotherapy, helps people with breast cancer that has spread to the liver live longer than chemotherapy alone. Researchers want to understand if taking out these tumors surgically—when it's possible to do so safely—gives patients a better chance of survival and improved quality of life.
Doctors have noticed that some patients seem to live longer when their liver tumors are surgically removed, but the medical community isn't yet sure if surgery truly helps or if chemotherapy alone is enough. This trial is designed to answer that important question definitively.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to one of two groups: either surgery to remove liver tumors followed by chemotherapy, or chemotherapy alone. You'll have regular visits to the hospital for checkups, scans, and treatment over an extended period. Researchers will track how you're doing, how long you survive, whether your cancer progresses, and how the treatment affects your quality of life.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Sweden